The Burden of VTE
Despite an incidence that exceeds 1 per 1,000 and data suggesting that VTE is the third most prevalent cardiovascular disease, the true burden posed by VTE is typically underestimated. There has been a tendency to both under-recognize the condition and underestimate its clinical and health-economic impact.
VTE and co-morbidities
To successfully evaluate a patient’s risk of VTE requires an appreciation of patient characteristics, disease characteristics and co-morbidities, and inherent risks in
Improving VTE Management
The prevention of VTE is important to avoid the morbid and potentially lethal effects of DVT and PE, as well as to reduce the future risk of recurrent VTE, the chronic health and cost burden of PTS, and the risks of pulmonary hypertension.